Indication
Sjogren-Larsson Syndrome
3 clinical trials
5 products
Product
ADX-102Product
ADX-102 Topical Dermal CreamClinical trial
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Trial to Evaluate the Safety and Efficacy of ADX-102 1% Topical Dermal Cream (Reproxalap) in Subjects With Sjögren-Larsson Syndrome (SLS)Status: Completed, Estimated PCD: 2020-01-18
Clinical trial
Phase II Study of the Safety, Pharmacokinetics, and Exploratory Activity of Once Daily (QD) Topical Application of NS2 Cream to Treat Ichthyosis in Subjects With Sjögren-Larsson Syndrome (SLS)Status: Completed, Estimated PCD: 2016-05-01
Product
Vehicle placeboClinical trial
An Open-Label, Phase 1/2, Single-Site Study of the Safety, Biochemical Efficacy, and Exploratory Clinical Effects of Oral ADX-629 in Subjects With Sjögren-Larsson SyndromeStatus: Recruiting, Estimated PCD: 2025-06-30
Product
ADX-629